News

AstraZeneca Confidently Pursues $80 Billion Revenue Target by 2030, Driven by New Medicines

Araverus Team|Tuesday, February 10, 2026 at 11:33 AM

Araverus Team

Feb 10, 2026 · 11:33 AM

AstraZeneca · Growth Strategy · Pharmaceutical · Revenue Goal

AstraZeneca Growth Strategy Pharmaceutical Revenue Goal

AstraZeneca is forecasting steady profit growth and is confident in reaching its ambitious goal of $80 billion in annual sales by 2030, driven by new medicines and investments, despite challenges from US policies.

AstraZeneca Confidently Pursues $80 Billion Revenue Target by 2030, Driven by New Medicines

Read More On

Related Articles

Societe Generale Raises 2026 Profitability Target

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

Cigna Revenue Lifted by Growth in its Evernorth Unit

AstraZeneca Confidently Pursues $80 Billion Revenue Target by 2030, Driven by New Medicines

Read More On

Related Articles

Societe Generale Raises 2026 Profitability Target

Novartis Forecasts Profitability Hit From Generic Drug Competition in U.S.

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

Cigna Revenue Lifted by Growth in its Evernorth Unit